Results 141 to 150 of about 5,684 (155)

Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis

EClinicalMedicine, 2023
Georgios V. Gkoutos, Kifah Hussain
exaly  

A green sustainable ultrasensitive micelle-sensitized spectrofluorimetric approach for the estimation of tafamidis in different matrices at picogram levels

Sustainable Chemistry and Pharmacy, 2023
Manal A Alossaimi, Heba Elmansi, Galal Magdy   +2 more
exaly  

Impact of tafamidis on myocardial strain in transthyretin amyloid cardiomyopathy

Amyloid: the International Journal of Experimental and Clinical Investigation: the Official Journal of the International Society of Amyloidosis, 2023
Bernhard Cherouny, Johannes Kästner
exaly  

Impact of Tafamidis on Echocardiographic Cardiac Function of Patients With Transthyretin Cardiac Amyloidosis

Circulation Journal, 2023
Susumu Odajima, Hiroaki Shiraki, Yuki Yamauchi   +2 more
exaly  

Effect of tafamidis on global longitudinal strain and myocardial work in transthyretin cardiac amyloidosis

European Heart Journal Cardiovascular Imaging, 2022
Sarah A M Cuddy, Rodney H Falk, Gérard Giblin   +2 more
exaly  

The Bioequivalence of Tafamidis 61-mg Free Acid Capsules and Tafamidis Meglumine 4 × 20-mg Capsules in Healthy Volunteers

Clinical Pharmacology in Drug Development, 2020
Steve Riley, Marla B Sultân, Terrell A Patterson   +2 more
exaly  

Effect of Tafamidis on Serum Transthyretin Levels in Non-Trial Patients With Transthyretin Amyloid Cardiomyopathy

JACC: CardioOncology, 2021
Sarah A M Cuddy, Rodney H Falk, Sharmila Dorbala   +2 more
exaly  

Tafamidis: A First-in-Class Transthyretin Stabilizer for Transthyretin Amyloid Cardiomyopathy

Annals of Pharmacotherapy, 2020
Hua Ling
exaly  

Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term extension studies.

European Heart Journal Quality of Care & Clinical Outcomes, 2022
Ahmad Masri, Bart Heeg, Andrea Garcia
exaly  

Follow-up Tc-99 m pyrophosphate cardiac scan for patients with transthyretin cardiac amyloidosis treated with tafamidis

Japanese Journal of Radiology, 2023
Tse-Hao Lee, Nan-Jing Peng
exaly